OrbiMed Israel BioFund GP Limited Partnership

CIK 1569821 · other company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for OrbiMed Israel BioFund GP Limited Partnership.

Recent SEC filings

FiledFormAccession number
Apr 9, 202640000947871-26-000421
Oct 10, 202540000947871-25-000898
Jun 23, 2025SCHEDULE 13D/A0000947871-25-000624
Jun 23, 2025SCHEDULE 13D/A0000947871-25-000626
Sep 16, 2024SC 13D/A0000947871-24-000757
Jul 17, 2024SC 13D/A0000947871-24-000626
May 20, 202440000947871-24-000498
Mar 19, 2024SC 13D/A0000947871-24-000290
Mar 19, 202440000947871-24-000289
Mar 11, 2024SC 13D/A0000947871-24-000279
Mar 8, 2024SC 13D/A0000947871-24-000273
Jan 26, 202440000950170-24-008053
Nov 15, 2023SC 13D/A0000947871-23-001083
Jun 29, 202340000947871-23-000713
May 8, 2023SC 13D/A0000947871-23-000538
Mar 17, 202340000947871-23-000336
Mar 17, 2023SC 13D/A0000947871-23-000335
Jan 5, 2023SC 13D/A0000947871-23-000013
Jan 5, 202340000947871-23-000015
Jul 1, 2022SC 13D/A0000947871-22-000739
Dec 14, 202140000947871-21-001280
Jul 30, 202140000947871-21-000844
Jun 28, 2021SC 13D/A0000947871-21-000717
Jun 25, 202140000947871-21-000712
May 13, 202140000947871-21-000520